Our research indicated that β‐elemene suppressed proliferation and enhanced sensitivity to gefitinib by inducing apoptosis through the FBP1/STAT3 axis in gefitinib‐resistant lung cancer cells. This evidence concerns the gene STAT3 and lung carcinoma.